QNCX
#4429
Quince Therapeutics, Inc. - Common Stock
34.7 0 USD
+0.07%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+6.77%
Variación mensual
+77.86%
Variación en los últimos 6 meses
+31445.45%
Cambio anual
+2198.01%
Cierres anteriores
32.5 0
Open
34.7 0
Mínimo
34.7 0
Máximo
34.7 0
Volumen
1
Financials
- Market Capitalization 35.29 M
- Employee 38
- Founded 2012
- CEO N/A
- Website www.quincetx.com
- Headquarter California, United States
- FIGI BBG00BTK1DT8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.99
Relación precio/flujo de caja
351.83
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4413 |  IGC IGC Pharma, Inc. Common Stock | 0.33 USD | +6.45% | +13.79% | +26.92% | +28.81% | 34.12 M USD | ||
| 4415 |  LITS Lite Strategy, Inc. - Common Stock | 1.00 USD | +1.01% | -3.85% | +3.09% | -66.44% | 34.03 M USD | ||
| 4430 |  KYNB Kyntra Bio, Inc. - Common Stock | 7.95 USD | -0.62% | +5.72% | +14.55% | -16.40% | 32.19 M USD | ||
| 4434 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.02 USD | -1.92% | -9.73% | +20.00% | -1.92% | 32.07 M USD |